These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 1715760)
1. Characterization of complement-independent neutralizing epitopes on pseudorabies virus glycoprotein gp50. Tsuda T; Yamada S; Murakami Y; Sugimura T J Vet Med Sci; 1991 Jun; 53(3):533-5. PubMed ID: 1715760 [No Abstract] [Full Text] [Related]
2. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus. Coe NE; Mengeling WL Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995 [TBL] [Abstract][Full Text] [Related]
3. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Eloit M; Fargeaud D; L'Haridon R; Toma B Arch Virol; 1988; 99(1-2):45-56. PubMed ID: 2833202 [TBL] [Abstract][Full Text] [Related]
4. Production and characterization of monoclonal antibodies directed against pseudorabies virus. Wathen LM; Platt KB; Wathen MW; Van Deusen RA; Whetstone CA; Pirtle EC Virus Res; 1985 Dec; 4(1):19-29. PubMed ID: 3002067 [TBL] [Abstract][Full Text] [Related]
5. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes. Fuchs W; Rziha HJ; Lukàcs N; Braunschweiger I; Visser N; Lütticken D; Schreurs CS; Thiel HJ; Mettenleiter TC J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164 [TBL] [Abstract][Full Text] [Related]
6. Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response. Zaripov MM; Morenkov OS; Siklodi B; Barna-Vetro I; Gyöngyösi-Horvath A; Fodor I Res Virol; 1998; 149(1):29-41. PubMed ID: 9561562 [TBL] [Abstract][Full Text] [Related]
7. Identification of antigenic sites on pseudorabies virus glycoprotein gp50 implicated in virus penetration of the host cell. Eloit M; Bouzghaia H; Toma B J Gen Virol; 1990 Sep; 71 ( Pt 9)():2179-83. PubMed ID: 1698927 [TBL] [Abstract][Full Text] [Related]
8. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Ben-Porat T; DeMarchi JM; Lomniczi B; Kaplan AS Virology; 1986 Oct; 154(2):325-34. PubMed ID: 2429441 [TBL] [Abstract][Full Text] [Related]
9. Epitope analysis of glycoprotein I of pseudorabies virus. Jacobs L; Meloen RH; Gielkens AL; Van Oirschot JT J Gen Virol; 1990 Apr; 71 ( Pt 4)():881-7. PubMed ID: 1691269 [TBL] [Abstract][Full Text] [Related]
10. Characterization of several pseudorabies viral strains by virus-neutralization test using monoclonal antibodies. Nosetto EO; Echeverria MG; Horimoto T; Pecoraro MR; Galosi CM; Tohya Y; Norimine J; Takahashi E; Etcheverrigaray ME; Mikami T Viral Immunol; 1997; 10(3):159-64. PubMed ID: 9344338 [TBL] [Abstract][Full Text] [Related]
11. Development of a competitive double antibody lateral flow assay for the detection of antibodies specific to glycoprotein B of Aujeszky's disease virus in swine sera. Vrublevskaya VV; Afanasyev VN; Grinevich AA; Skarga YY; Gladyshev PP; Ibragimova SA; Krylsky DV; Morenkov OS J Virol Methods; 2017 Feb; 240():54-62. PubMed ID: 27894861 [TBL] [Abstract][Full Text] [Related]
12. Glycoprotein gI of pseudorabies virus: epitope-specific antibody response in mice and pigs. Jacobs L; Moonen-Leusen BM; Bianchi AT; Kimman TG Acta Vet Hung; 1994; 42(2-3):347-51. PubMed ID: 7528969 [No Abstract] [Full Text] [Related]
13. Protection from pseudorabies virus challenge in mice by a combination of purified gII, gIII and gVI antigens. Matsuda Tsuchida A; Katayama S; Okada N; Okabe T; Sasaki N J Vet Med Sci; 1992 Jun; 54(3):447-52. PubMed ID: 1322712 [TBL] [Abstract][Full Text] [Related]
14. A complement-dependent neutralizing monoclonal antibody against glycoprotein II of pseudorabies virus. Nakamura T; Ihara T; Nagata T; Ishihama A; Ueda S Vet Microbiol; 1990 Aug; 24(2):193-8. PubMed ID: 2173250 [TBL] [Abstract][Full Text] [Related]
15. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. Eloit M; Gilardi-Hebenstreit P; Toma B; Perricaudet M J Gen Virol; 1990 Oct; 71 ( Pt 10)():2425-31. PubMed ID: 2172456 [TBL] [Abstract][Full Text] [Related]
17. Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design. Li X; Yang F; Hu X; Tan F; Qi J; Peng R; Wang M; Chai Y; Hao L; Deng J; Bai C; Wang J; Song H; Tan S; Lu G; Gao GF; Shi Y; Tian K PLoS Pathog; 2017 Dec; 13(12):e1006777. PubMed ID: 29261802 [TBL] [Abstract][Full Text] [Related]
18. Production of a baculovirus-derived gp50 protein and utilization in a competitive enzyme-linked immunosorbent assay for the serodiagnosis of pseudorabies virus. Prud'homme I; Zhou EM; Traykova M; Trotter H; Chan M; Afshar A; Harding MJ Can J Vet Res; 1997 Oct; 61(4):286-91. PubMed ID: 9342453 [TBL] [Abstract][Full Text] [Related]
19. Characterization of pseudorabies virus glycoprotein B expressed by canine herpesvirus. Nishikawa Y; Xuan X; Kimura M; Otsuka H J Vet Med Sci; 1999 Oct; 61(10):1113-7. PubMed ID: 10563288 [TBL] [Abstract][Full Text] [Related]
20. Isolation of mutants of Aujeszky's disease virus with antigenically altered glycoprotein E by affinity chromatography using monoclonal antibodies. Morenkov OS; Smirnov SV; Vrublevskaya VV J Virol Methods; 1999 Jan; 77(1):101-8. PubMed ID: 10029330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]